Sanjiv Bhasin suggests that investing in the pharmaceutical sector can serve as a good proxy to the weak rupee. He recommends two pharma stocks as top bets. Read on to find out more about these investment opportunities.
Kenneth Andrade shares his investment strategy, revealing why he is steering clear of banks and financials while focusing on power and pharma stocks.
Sanjiv Bhasin, Director of IIFL Securities, shares insights on the changing market dynamics and provides recommendations for investors. He discusses the leadership shift from banks to IT and pharma sectors, highlights the performance and future outlook of specific stocks, and discusses the potential of the insurance sector and the pharma industry.
Indian equity markets opened higher on Thursday, led by banking, financial, and IT stocks ahead of the release of the Reserve Bank of India’s policy meeting minutes. The BSE Sensex and Nifty50 were trading higher. Experts have a positive outlook on the near-term market. Global markets settled higher and Asian markets advanced. Oil prices slipped, while the Indian rupee strengthened against the US dollar.
